Innovassynth Technologies (India) Ltd

Innovassynth Technologies (India) Ltd

BBSE:INOVSYNTH
160.40
INR
-0.85
(-0.53%)
0.84EPS
154.28P/E
12.01BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
17.43
12
18.16
Basic EPS, GAAP
-0.06
-0.09
-0.12
-0.13
-0.14
-0.2
-0.2
-0.19
0.45
-0.58
-0.31
3.63
-3.43
0.84
Free Cash Flow per Basic Share
-0.07
-0.07
-0.08
-0.07
-0.05
-0.18
-0.13
-0.1
-0.12
-0.13
-0.12
2.3
-5.43
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
8.73
8.65
8.53
8.4
8.26
7.59
7.42
7.35
13.68
13.66
13.35
39.54
11.25
- -
Tangible Book Value per Share
8.73
8.65
8.53
8.4
8.26
7.59
7.42
7.35
13.68
13.66
13.35
39.41
11.17
- -
Basic Weighted Avg Shares
27
27
27
27
27
27
27
28
27
27
27
55
84
71
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
967
1,008
1,288
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
17.71
-31.24
8.62
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
39
79
59
Net Income, GAAP
-2
-2
-3
-3
-4
-5
-5
-5
12
-16
-8
201
-288
59
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
20.84
-28.57
4.62
Working Capital
-2
-5
-8
-11
-15
-21
-26
-31
-38
-44
-51
-12
-99
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
181
574
- -
Total Equity
236
234
230
227
223
205
200
199
370
369
361
1,232
945
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-1.21
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
4.78
- -
- -
- -
- -
- -
Return on Common Equity (%)
-0.74
-1.01
-1.37
-1.5
-1.68
-2.53
-2.69
-2.61
4.28
-4.27
-2.31
25.3
-26.45
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
552
- -
LT Borrowings
- -
486
- -
LT Finance Leases
- -
88
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
84
84
93
Market Capitalization
6,072
5,218
12,012

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,141
- -
Cash, Cash Equivalents & STI
- -
20
- -
Accounts Receivable, Net
- -
314
- -
Inventories
- -
559
- -
Total Current Liabilities
- -
1,239
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
552
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.74%
60.38%
-23.28%
Free Cash Flow
-430.25%
-892.58%
-457.42%
Net Income, GAAP
-328.11%
-667.75%
-242.9%
Sales/Revenue/Turnover
- -
- -
4.23%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
499
484
967
2026
123
- -
220
508
1,008
2027
560
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-2.17
-2.21
2.95
3.73
3.63
2026
-6
-1.59
-0.93
1.42
-3.43
2027
0.8
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Hardik Joshipura
Full Time Employees
283
Sector
Miscellaneous
Industry
Miscellaneous
Address
Old Mumbai Khopoli MA India 410 203
IPO Date
Feb 7, 2011
Business
Innovassynth Investments Limited is a diversified investment company headquartered in India, primarily engaged in managing a portfolio of investments across various sectors including chemicals, pharmaceuticals, and specialty ingredients. The company’s core products and services include chemical manufacturing and distribution, pharmaceutical intermediates production, and specialty chemical solutions for agrochemicals, polymers, and other industrial applications. Innovassynth serves both domestic and international markets with a focus on delivering innovative and sustainable chemical products. Founded in 1975, Innovassynth Investments Limited operates mainly in India with expanding interests in global markets through strategic partnerships and alliances. Recent major company changes include new strategic investments to expand its chemical manufacturing capabilities and the launch of advanced specialty chemical product lines tailored for high-growth industries. The company has also pursued acquisitions to diversify its product portfolio and strengthen its market presence within specialty chemicals and pharmaceuticals sectors, aligning with its broader growth and innovation strategy. Innovassynth Investments Limited targets business segments including chemical manufacturing, pharmaceuticals, and specialty ingredients with a strong emphasis on research and development to deliver value-added products. The company is positioned within the chemical and pharmaceutical industries, serving manufacturers, industrial clients, and commercial distributors. It leverages its extensive industry expertise and operational footprint to maintain competitiveness and expand market share in India and select international regions. Through continuous innovation, strategic investments, and operational enhancements, Innovassynth Investments Limited reinforces its commitment to growth within specialty chemicals and pharmaceuticals, reflecting its long-standing industry experience and forward-looking business strategy. It stands as a notable player in India's chemical industry with its comprehensive product offerings, operational scale, and evolving market strategies.